- Mitarbeiter
- 1 - 10
- Offene Stellen
- 0
- Branche
- Maschinenbau, Kfz, Metall
Über uns
Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs.
Our lead compound reduces Chemotherapy-induced Neutropenia, the most common and most serious side effect of anticancer therapy.
Myelo Therapeutics was selected 2014 as one of the “Top 40 High Tech Ventures of the East”.
The company was founded in 2013 and currently has 7 employees.